The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E232 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: Clozapine with Dr. Jonathan Meyer
52:29
52:29
Play later
Play later
Lists
Like
Liked
52:29
What are the primary barriers to clozapine utilization in the United States, and how do these barriers impact patient care? What are some common misconceptions or negative attitudes among prescribers regarding clozapine, and how can these be addressed? What are some effective strategies for improving the management of clozapine’s side effects to en…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E231 - The 2023 NEI Congress Young Investigator Poster Competition #1 Poster with Dr. Richard Price
49:56
49:56
Play later
Play later
Lists
Like
Liked
49:56
Join Dr. Andy Cutler as he talks with the co-author of the winning poster from the 2023 NEI Congress Young Investigator Poster Competition, Dr. Richard Price. They discuss the objectives, design, and key findings of the poster titled, “Improved Mood and Weight Gain Mitigation Following Switch from Aripiprazole to Cariprazine.” They also discuss the…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E230 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: MAOIs with Dr. Thomas Schwartz
51:31
51:31
Play later
Play later
Lists
Like
Liked
51:31
What are the main reasons MAOIs are underutilized in psychiatric practice despite their proven efficacy for certain conditions? What are the key dietary restrictions patients must follow when taking MAOIs? What are the critical drug-drug interactions clinicians must be aware of when prescribing MAOIs? What clinical pearls or tips would you give to …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E229 - Treatment Approaches for Smoking Cessation in the LGBTQIA+ Community with Dr. Rhonda Schwindt
1:02:38
1:02:38
Play later
Play later
Lists
Like
Liked
1:02:38
What are the current smoking rates among LGBTQIA+ individuals compared to the general population? What unique barriers do LGBTQIA+ individuals face when trying to quit smoking? What are the recommended pharmacotherapies and behavioral interventions for smoking cessation? What training is needed for providers to deliver culturally affirmative smokin…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E228 - (CME) Tardive Dyskinesia Today: Updates in the Current Landscape of Tardive Dyskinesia
1:07:06
1:07:06
Play later
Play later
Lists
Like
Liked
1:07:06
In this CME episode, Dr. Andrew Cutler interviews Dr. Laxman Bahroo about the current landscape of tardive dyskinesia, including screening, diagnosis, and treatment. Practical strategies based on the latest data are reviewed at length, particularly for long-term management of tardive dyskinesia. Target Audience: This activity has been developed for…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E227 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: Lithium with Dr. Jonathan Meyer
1:03:34
1:03:34
Play later
Play later
Lists
Like
Liked
1:03:34
What are the properties of lithium that make it a unique treatment option? What are the main reasons why lithium is underutilized in clinical practice, and what are the consequences of underutilization? What are the common myths or misconceptions about lithium’s safety and tolerability? How can we better educate patients about the benefits of lithi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E226 - (CME) Symptoms Speak: Engaging Patients in the Tardive Dyskinesia Conversation
58:43
58:43
Play later
Play later
Lists
Like
Liked
58:43
In this CME episode, Dr. Andrew Cutler interviews Desiree Matthews, PMHNP-BC on the importance of engaging patients across all facets of tardive dyskinesia management beginning with screening to symptoms monitoring to treatment. The role of patient experience and preferences in shared decision-making regarding treatment for tardive dyskinesia is di…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E225 - The PsychopharmaStahlogy Show: Untreatable Dimensions of Psychopathology: Agitation with Dr. Leslie Citrome
52:38
52:38
Play later
Play later
Lists
Like
Liked
52:38
How do symptoms of agitation manifest differently in disorders such as bipolar disorder, schizophrenia, and dementia, and what challenges does this pose for assessment? What are the most effective pharmacological treatments for acute agitation in psychiatric patients, and how do you determine the best course of action? How do cultural factors influ…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E224 - Is Cannabidiol Useful for the Treatment of Opioid Use Disorder? with Dr. Joji Suzuki
52:02
52:02
Play later
Play later
Lists
Like
Liked
52:02
What are the hypothesized neurobiological mechanisms that support the use of cannabidiol (CBD) as a treatment for opioid use disorder (OUD)? How does CBD influence cue-induced craving in OUD? What are the challenges and opportunities in further exploring the use of CBD as a potential treatment for OUD? Dr. Joji Suzuki is the Director of the Divisio…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E223 - 2024 NEI Synapse Extended Q&A: Diagnosing and Treating Comorbid ADHD and Bipolar Disorder with Dr. David Goodman
27:34
27:34
Play later
Play later
Lists
Like
Liked
27:34
In this episode, Dr. David Goodman addresses your unanswered questions from his presentation, Setting the Mood: Strategies for Diagnosing and Treating ADHD in the Context of Bipolar Disorder, delivered at 2024 NEI Synapse in Las Vegas, Nevada.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E222 - 2024 NEI Synapse Extended Q&A: Recognizing and Treating Mixed Features Across the Lifespan with Dr. Manpreet Singh
21:15
21:15
Play later
Play later
Lists
Like
Liked
21:15
In this episode, Dr. Manpreet Singh addresses your unanswered questions from her joint presentation, Don’t Get Mixed Up! Recognizing and Treating Mixed Features Across the Lifespan, delivered at 2024 NEI Synapse in Las Vegas, Nevada.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E221 - 2024 NEI Synapse Extended Q&A: Diagnosis and Treatment of Alzheimer’s Disease with Dr. Dani Cabral
13:49
13:49
Play later
Play later
Lists
Like
Liked
13:49
In this episode, Dr. Dani Cabral addresses your unanswered questions from her presentation, Memories in the Future: An Update on the Diagnosis and Treatment of Alzheimer’s Disease, delivered at 2024 NEI Synapse in Las Vegas, Nevada.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E220 - 2024 NEI Synapse Extended Q&A: A Collaborative Approach to SMI Treatment with Dr. Sarah Vinson
25:57
25:57
Play later
Play later
Lists
Like
Liked
25:57
In this episode, Dr. Sarah Vinson addresses your unanswered questions from her panel presentation, Serious Mental Illness: A Collaborative Approach, delivered at 2024 NEI Synapse in Las Vegas, Nevada.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E219 - The PsychopharmaStahlogy Show: Untreatable Dimensions of Psychopathology: Cognitive Dysfunction with Dr. Richard Keefe
1:04:48
1:04:48
Play later
Play later
Lists
Like
Liked
1:04:48
How does dysfunction in cognition affect overall treatment outcomes for psychiatric disorders? What are the challenges in treating cognitive deficits in psychiatric conditions? What treatments are in development for cognitive dysfunction? Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exciting, and controve…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E218 - Dementia Caregiving and the New GUIDE Model with Dr. Carolyn Clevenger
53:09
53:09
Play later
Play later
Lists
Like
Liked
53:09
What are some common challenges faced by caregivers of individuals with dementia? What is comprehensive dementia care and how does it improve quality of life of individuals with dementia and their caregivers? What is the GUIDE Model and why is it needed? Carolyn Clevenger, DNP, RN, GNP-BC, AGPCNP-BC, FAANP, FGSA is a Professor at the Nell Hodgson W…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E217 - Mindfulness-Based Stress Reduction for Anxiety Disorders with Dr. Elizabeth Hoge
53:25
53:25
Play later
Play later
Lists
Like
Liked
53:25
What is the role of mindfulness techniques in the treatment of anxiety disorders and how is it evolving? How does mindfulness-based stress reduction compare to pharmacological treatment for anxiety disorders? What are the hypotheses that have been made about why mindfulness-based treatments work for anxiety? Elizabeth Hoge, MD is a Professor and Di…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E216 - Migrant and Refugee Mental Health with Dr. Lisa Fortuna
54:07
54:07
Play later
Play later
Lists
Like
Liked
54:07
What are the cultural factors that should be considered when providing mental health care to migrant and refugee populations? What challenges and opportunities exist in providing mental health care to these communities? How can mental health professionals collaborate with other disciplines to create a holistic approach to address the mental health …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E215 - The PsychopharmaStahlogy Show: Untreatable Dimensions of Psychopathology: Anhedonia with Dr. Vladimir Maletic
47:43
47:43
Play later
Play later
Lists
Like
Liked
47:43
How does anhedonia impact the overall treatment plan for patients with major depressive disorder and other psychiatric conditions? What are some of the most challenging aspects of treating anhedonia in patients? Are there any new treatments in development that may be helpful for treating anhedonia? Brought to you by the NEI Podcast, the Psychopharm…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E214 - Re-Release: Blazing Trails to Break Down Structural Racism and Improve Black Mental Health with Dr. Sarah Vinson
21:37
21:37
Play later
Play later
Lists
Like
Liked
21:37
During Black History Month, we revisit an enlightening conversation with Dr. Sarah Vinson about the impact of structural racism on Black mental health and how mental healthcare providers can make a difference in the lives of patients by leveraging their privilege and skillsets. Dr. Sarah Y. Vinson is a physician who is triple-board certified in adu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E213 - The PsychopharmaStahlogy Show: Is The Trip Necessary? with Dr. Charles Raison
1:01:33
1:01:33
Play later
Play later
Lists
Like
Liked
1:01:33
Can the therapeutic benefits of psilocybin be achieved without a psychedelic trip? What is the role of psychological support in the therapeutic effect of psilocybin? What is microdosing and what are its potential benefits and risks? What is the path to FDA approval and commercialization of psilocybin and other psychedelics? Brought to you by the NE…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E212 - Climate Crisis and Mental Health with Dr. Robin Cooper
54:53
54:53
Play later
Play later
Lists
Like
Liked
54:53
The climate crisis has a wide-reaching impact that negatively affects both acute and long-lasting mental health outcomes. Are there specific populations that are more vulnerable to mental health issues related to the climate crisis? What is the role of mental health professional to combat the negative influence of climate change on mental health? R…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E211 - (CME) More Than Memories: An Update on the Diagnosis and Treatment of Alzheimer’s Disease
1:00:04
1:00:04
Play later
Play later
Lists
Like
Liked
1:00:04
In this CME episode, Dr. Andrew Cutler interviews Dr. Dani Cabral about current and novel diagnostic tools and treatments for Alzheimer’s disease. Optional CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CE credit, click nei.global/POD23-MDD Learning Objectives: After completing thi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E210 - The PsychopharmaStahlogy Show: Potential Therapeutic Indications for Psychedelics with Dr. Scott Aaronson
58:41
58:41
Play later
Play later
Lists
Like
Liked
58:41
What do the clinical trials of psilocybin and other psychedelics show in terms of efficacy and safety? How much of the benefit with psychedelic treatment is attributable to psychological support? Is the psychedelic trip important for the therapeutic benefits of psychedelic treatments? Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E209 - (CME) Harnessing Pharmacogenomic Testing as a Tool in Major Depressive Disorder Treatment
1:02:22
1:02:22
Play later
Play later
Lists
Like
Liked
1:02:22
In this CME episode, Dr. Andrew Cutler interviews Dr. Jeffrey Strawn about the role of pharmacogenomic testing in guiding treatment of major depressive disorder (MDD). They discuss how pharmacogenomic testing works, the impact of failed treatments and side effects on patients with MDD, and the clinical applications and future directions of pharmaco…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E208 - A Look Back at This Year in Psychopharmacology with Dr. Roger McIntyre
1:08:42
1:08:42
Play later
Play later
Lists
Like
Liked
1:08:42
What were some new treatments approved by the FDA? What did we learn about the long-term safety of methylphenidate in childhood ADHD? Are there benefits to long-term maintenance treatment with antidepressants in bipolar disorder? What did we learn about the safety and efficacy of subcutaneous racemic ketamine for treatment-resistant depression and …
…
continue reading